Clinical course of primary immune thrombocytopenia with positive antiphospholipid antibodies
- 1 November 2019
- journal article
- letter
- Published by Elsevier in European Journal of Internal Medicine
- Vol. 69, e6-e7
Abstract
No abstract availableKeywords
Funding Information
- São Paulo Research Foundation (2016/14172-6)
This publication has 11 references indexed in Scilit:
- Relevance of antiphospholipid antibody profile in the clinical outcome of ITP: a single-centre studyHematology, 2018
- Laboratory criteria for antiphospholipid syndrome: communication from the SSC of the ISTHJournal of Thrombosis and Haemostasis, 2018
- Incidence of Antiphospholipid Antibodies in Patients With Immune Thrombocytopenia and Correlation With Treatment With Steroids in North Indian PopulationClinical and Applied Thrombosis/Hemostasis, 2016
- The relevance of “non-criteria” clinical manifestations of antiphospholipid syndrome: 14th International Congress on Antiphospholipid Antibodies Technical Task Force Report on Antiphospholipid Syndrome Clinical FeaturesAutoimmunity Reviews, 2015
- Testing for Antiphospholipid antibodies with Solid Phase Assays: guidance from the SSC of the ISTHJournal of Thrombosis and Haemostasis, 2014
- Antiphospholipid-associated thrombocytopenia or autoimmune hemolytic anemia in patients with or without definite primary antiphospholipid syndrome according to the Sapporo revised classification criteria: a 6-year follow-up studyBlood, 2010
- Update of the guidelines for lupus anticoagulant detectionJournal of Thrombosis and Haemostasis, 2009
- Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working groupBlood, 2009
- Antiphospholipid antibodies in adults with immune thrombocytopenic purpuraBritish Journal of Haematology, 2008
- International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)Journal of Thrombosis and Haemostasis, 2006